A biomedical engineer pivots from human movement to women’s health
Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.
Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.
For two decades, MIT-Mexico has funded student internships and teaching, as well as faculty research collaborations.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
The longtime academic leader of the Harvard-MIT Program in Health Sciences and Technology reflects on her time spent guiding students at the intersection of medicine and engineering.
An MRI method purported to detect neurons’ rapid impulses produces its own misleading signals instead, an MIT study finds.
MIT researchers plan to search for proteins that could be used to measure electrical activity in the brain.
MIT senior Daisy Wang interweaves biological engineering and women’s and gender studies as a way to address social problems.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Marcos Berríos ’06, Christina Birch PhD ’15, and Christopher Williams PhD ’12, now eligible for spaceflight assignments, encourage MIT students to apply for the next astronaut class.
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
Materials from MIT’s Distinctive Collections reveal stories of women at the Institute.
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Award honors “scientists who have made a transformational contribution toward the improvement of human health.”